SEC Tracker
Get the app

TrueBlue TBI

TrueBlue Q3 FY25: net loss $1.9M; diluted EPS −$0.06

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers TrueBlue reported for Q3 FY25, the quarter ended Sep 28, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Net income−$1.9MAgainst −$7.6M in Q3 FY2410-Q income statement, on EDGAR
  2. Diluted EPS−$0.06Against −$0.26 in Q3 FY2410-Q income statement, on EDGAR
  3. Cash and cash equivalents$19.9M+37% from $14.5M in Q3 FY2410-Q balance sheet, on EDGAR
  4. Cash from operations−$19.8MAgainst −$7.1M in Q3 FY2410-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when TrueBlue files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 7363 and related industry codes: the same peer list as the financial tables.

  1. Heidrick & Struggles International HSII
  2. Kelly Services KELYA public float $364M, Jun 29, 2025
  3. Cross Country Healthcare CCRN public float $393M, Jun 30, 2025
  4. RCM Technologies RCMT public float $99M, Jun 27, 2025
  5. Circle8 Group ATLN public float $98M, Jun 30, 2025